Title
Category
Credits
Event date
Cost
Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics
  • Bipolar Disorder
  • Antipsychotics
  • Women’s Mental Health
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
What do data from a pregnancy registry demonstrate about the risk of major malformations among infants exposed to second-generation antipsychotics during the first trimester?
Postpartum Depression and Psychosis and Subsequent Severe Mental Illnesses in Mothers and Neurodevelopmental Disorders in Children: A Nationwide Study
  • Bipolar Disorder
  • Depression
  • Attention-Deficit/Hyperactivity Disorder
  • Autism Spectrum Disorders
  • Child and Adolescent Psychiatry
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Women’s Mental Health
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Is there an association between postpartum depression or psychosis and subsequent disorders in either the mother or the child who is exposed to postpartum maternal illness?
Barriers and Pathways to Changing Smoking and Risky Drinking in Primary Care Patients With Chronic Conditions Who Failed to Respond to Brief Advice
  • Medical Conditions
  • Primary Care
  • Smoking
  • Substance Use Disorders
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Many individuals who smoke tobacco or consume alcohol at hazardous levels have chronic conditions that are caused or exacerbated by these behaviors. How might you help these patients to change?
Prevalent Gaps in Understanding the Features of Catatonia Among Psychiatrists, Psychiatry Trainees, and Medical Students
  • Catatonia
  • Diagnostic Tools
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Underdiagnosis of catatonia may occur because of its heterogeneous phenotypes and a lack of harmony between the DSM-5 and the Bush-Francis Catatonia Rating Scale.
Measurement-Based Diagnosis and Treatment for Tardive Dyskinesia
  • Bipolar Disorder
  • Depression
  • Antipsychotics
  • Diagnostic Tools
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Experts offer a review of the fundamentals of diagnosing and treating tardive dyskinesia.
Treatment-Resistant Schizophrenia: Definition, Predictors, and Therapy Options
  • Antipsychotics
  • Schizophrenia/ Schizoaffective Disorders
  • Side Effects
  • Treatment Resistance
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Two experts offer a refresher on predictors and identification of treatment-resistant schizophrenia. Drs Correll and Howes also review therapeutic strategies.
The Efficacy of Measurement-Based Care for Depressive Disorders: Systematic Review and Meta-Analysis of Randomized Controlled Trials
  • Depression
  • Delivery of Care
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
For patients with depressive disorders treated with pharmacotherapy, measurement-based care is effective in decreasing symptom severity, promoting remission, and improving medication adherence.
Diagnosing and Treating Insomnia in Adults and Older Adults
  • Sleep
  • Diagnostic Tools
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Drs Rosenberg and Krystal identify key steps in the diagnosis and treatment of insomnia disorder.
Individualizing Treatment Selection for Pediatric and Adult Patients With Bipolar Depression
  • Bipolar Disorder
  • Depression
  • Antidepressants
  • Antipsychotics
  • Child and Adolescent Psychiatry
  • Diagnostic Tools
  • Mood Disorders
  • Patient/Physician Communication
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Drs Findling and Goldberg offer expertise on the diagnosis and treatment of bipolar disorder in patients of all ages.
Do Not Drink, Do Not Drive: Alcohol Use Disorder in the Elderly
  • Cognition
  • Geriatric Psychiatry
  • Primary Care
  • Substance Use Disorders
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
When older patients present with cognitive decline, it is important to rule out any organic, mood-related, or substance-induced etiology, such as alcohol use disorder.

Pages